- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
10x Genomics (TXG)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 432.71 mm | 432.71 mm | 432.71 mm | 432.71 mm | 432.71 mm | 432.71 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 10.75 mm | 7.03 mm | (no burn) | (no burn) |
| Cash used (since last report) | n/a | n/a | 25.97 mm | 17.00 mm | n/a | n/a |
| Cash remaining | n/a | n/a | 406.74 mm | 415.71 mm | n/a | n/a |
| Runway (months of cash) | n/a | n/a | 37.8 | 59.1 | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 272 |
| Opened positions | 64 |
| Closed positions | 55 |
| Increased positions | 85 |
| Reduced positions | 90 |
| 13F shares | Current |
|---|---|
| Total value | 1.42 tn |
| Total shares | 116.20 mm |
| Total puts | 132.10 k |
| Total calls | 76.40 k |
| Total put/call ratio | 1.7 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 13.45 mm | $193.21 bn |
| ARK Investment Management | 11.94 mm | $171.52 bn |
| Vanguard | 10.93 mm | $157.01 bn |
| BlackRock | 6.77 mm | $97.22 bn |
| CMTDF Sumitomo Mitsui Trust | 5.71 mm | $82.05 bn |
| Nikko Asset Management Americas | 5.71 mm | $82.05 bn |
| Venrock Associates VI | 4.83 mm | $0.00 |
| MS Morgan Stanley | 3.93 mm | $56.37 bn |
| Ra Capital Management | 3.28 mm | $47.09 bn |
| Meritech Capital Partners V | 2.58 mm | $365.47 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Nov 25 | Saxonov Serge | Class A Common Stock | Sell | Dispose S | No | No | 18.9983 | 13,261 | 251.94 k | 1,021,556 |
| 24 Nov 25 | Hindson Benjamin J. | Class A Common Stock | Sell | Dispose S | No | No | 18.9983 | 8,283 | 157.36 k | 432,605 |
| 24 Nov 25 | Adam Taich | Class A Common Stock | Sell | Dispose S | No | No | 18.9983 | 11,888 | 225.85 k | 297,385 |
| 12 Sep 25 | Saxonov Serge | Class A Common Stock | Gift | Dispose G | No | No | 0 | 900 | 0.00 | 1,034,817 |
| 22 Aug 25 | Hindson Benjamin J. | Class A Common Stock | Sell | Dispose S | No | No | 13.787 | 7,486 | 103.21 k | 440,888 |